SMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain
SMART-CART-AMI
Observational and Prospective Diagnostic Validation Study of the SMARTwatch for ST-segment Elevation Myocardial Infarction in Health Area of Cartagena
1 other identifier
observational
100
1 country
1
Brief Summary
The main symptom that initiates the diagnostic and therapeutic process for patients with suspected acute coronary syndrome is chest pain. Based on a standard 12-lead electrocardiogram (ECG), patients can be diagnosed with ST-segment elevation myocardial infarction (STEMI), which requires immediate medical treatment. Recently, wearable devices like smartwatches with ECG capabilities have opened new pathways for cardiac triage, but their diagnostic precision and technical viability in a real, unselected Emergency Department setting need to be confirmed. The primary objective of this prospective, observational study is to compare the diagnostic capacity of a 9-lead ECG obtained with a smartwatch against the standard 12-lead ECG for diagnosing STEMI in patients consulting for chest pain. During the study, patients evaluated by the on-call cardiologist for ischemic chest pain will undergo their standard care. In addition to the standard 12-lead ECG, a 9-lead ECG will be sequentially recorded using a smartwatch. This is an observational study, meaning the smartwatch recording will not cause any delay in clinical action or negatively impact the patient's standard treatment. Specifically, the study aims to:
- Analyze the diagnostic agreement between expert cardiologists when blindly and independently classifying the smartwatch recordings versus the standard ECG recordings as "STEMI" or "non-STEMI".
- Evaluate the technical feasibility of using the smartwatch in an Emergency Department setting by assessing the percentage of unreadable records due to artifacts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 14, 2026
CompletedFirst Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
August 26, 2026
August 1, 2026
6 months
August 19, 2026
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Smartwatch ECG records' ability to diagnose STEMI
Analyze the diagnostic agreement between expert cardiologists when blindly and independently classifying the smartwatch recordings versus the standard ECG recordings as "STEMI" or "non-STEMI".
From enrollment to the blinded analysis at the end of the recruitment
Study Arms (1)
General cohort
Interventions
Eligibility Criteria
The study population consists of unselected patients presenting to the Emergency Department at Hospital Universitario Santa Lucía (Cartagena) who are evaluated by the on-call cardiologist for ischemic-profile chest pain. This represents a real-world clinical cohort in an acute setting. Patients with extreme hemodynamic instability (where an additional recording would delay critical emergency treatment) and those with baseline electrocardiogram alterations (such as prior left bundle branch block or pacemaker-mediated pacing) that preclude proper ST-segment interpretation are excluded from this population.
You may qualify if:
- Patients evaluated by the on-call cardiologist for chest pain with an ischemic profile.
You may not qualify if:
- Patients with extreme hemodynamic instability where the additional recording would cause an ethically unacceptable delay in their treatment.
- Patients with a prior diagnosis of left bundle branch block or pacemaker-mediated pacing.
- Patients who decline participation in the registry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital General Universitario Santa Lucia
Cartagena, Murcia, 30202, Spain
Related Publications (1)
Spaccarotella CAM, Polimeni A, Migliarino S, Principe E, Curcio A, Mongiardo A, Sorrentino S, De Rosa S, Indolfi C. Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes. JAMA Cardiol. 2020 Oct 1;5(10):1176-1180. doi: 10.1001/jamacardio.2020.3994.
PMID: 32865545BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 24, 2026
Study Start
August 14, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
August 26, 2026
Record last verified: 2026-08